Malaysian Genomics Resource (0155) — Capital Reinvestment Ratio
Latest as of March 2026:
0.06x
Malaysian Genomics Resource (0155) has a Capital Reinvestment Ratio of 0.06x as of March 2026, meaning it reinvests 0% of its operating cash flow (RM98.00K) in capital expenditures (RM6.00K). See free cash flow generation of Malaysian Genomics Resource to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
RM98.00K
MYR
Capital Expenditures
RM6.00K
MYR
Data as of
Mar 2026
Most recent filing
Malaysian Genomics Resource Capital Reinvestment Ratio (2015–2026)
This chart tracks Malaysian Genomics Resource's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Malaysian Genomics Resource (2015–2026)
Year-by-year Capital Reinvestment Ratio for Malaysian Genomics Resource from 2015 to 2026. For live market cap and broader valuation context, see 0155 company net worth.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.06x | RM1.10 Million | RM71.64K | ▼ -99.7% |
| 2022 | 23.38x | RM56.92K | RM1.33 Million | ▲ +77574.7% |
| 2020 | 0.03x | RM11.67 Million | RM351.18K | ▼ -22.9% |
| 2017 | 0.04x | RM3.67 Million | RM143.49K | ▼ -20.7% |
| 2016 | 0.05x | RM3.68 Million | RM181.42K | ▼ -93.9% |
| 2015 | 0.80x | RM395.83K | RM318.34K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow